These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16457151)

  • 1. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
    Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
    Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
    Im SA; Lee KE; Nam E; Nam SH; Kim DY; Seong CM; Park HY; Han WS; Seoh JY; Lee SN
    Cancer Res Treat; 2003 Apr; 35(2):109-16. PubMed ID: 26680923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
    Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
    Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
    Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
    World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
    Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
    Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
    Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
    J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
    Zhang J; Guo L; Liu X; Li W; Ying J
    Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
    Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
    J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.
    Sajjadi E; Venetis K; Piciotti R; Gambini D; Blundo C; Runza L; Ferrero S; Guerini-Rocco E; Fusco N
    BMC Cancer; 2021 Oct; 21(1):1152. PubMed ID: 34706703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 status in unusual histological variants of gastric adenocarcinomas.
    Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
    J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
    Zhang Z; Wang B; Huang G; Wang R; Song J; Lin S; Wang W; Jiang Y; Huang Q; Wang L
    Clin Lab; 2017 Jan; 63(1):115-125. PubMed ID: 28164509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
    Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
    World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
    World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.
    Zhang X; Park JS; Park KH; Kim KH; Jung M; Chung HC; Rha SY; Kim HS
    Oncology; 2015; 88(2):76-85. PubMed ID: 25300346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.